G13.1Billable

Other systemic atrophy primarily affecting central nervous system in neoplastic disease

Short description: Oth systemic atrophy aff cnsl in neoplastic disease

Chapter
6. Diseases of the nervous system
Category
G13
Effective date
October 1, 2026

Related codes in category G13

G13Systemic atrophies aff cnsl in diseases classd elswhrG13.0Paraneoplastic neuromyopathy and neuropathyYesG13.2Systemic atrophy primarily affecting the cnsl in myxedemaYesG13.8Systemic atrophy aff cnsl in oth diseases classd elswhrYes

Frequently asked questions

What is ICD-10 code G13.1?

G13.1 is an ICD-10-CM diagnosis code for Other systemic atrophy primarily affecting central nervous system in neoplastic disease.

Is G13.1 a billable code?

Yes. G13.1 is billable and specific enough to be used on a claim.

What ICD-10-CM chapter is G13.1 in?

G13.1 falls under Chapter 6: Diseases of the nervous system.

When did G13.1 become effective?

G13.1 has been effective since October 1, 2026, per the CMS/CDC ICD-10-CM annual release.

What other codes are related to G13.1?

G13.1 belongs to category G13, which includes 4 other codes — see the related codes list on this page.

ICD-10-CM data maintained by CDC/CMS (public domain). Always verify codes with authoritative sources before making coding or billing decisions.